Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Skateron Feb 07, 2020 10:13am
74 Views
Post# 30657612

RE:Austerity scenarios

RE:Austerity scenariosBiggest risk is not dilution, it is running out of cash.  Period.  From Financial Post:

“Aurora is in a precarious position as its cash needs are likely to exhaust the resources at hand, including roughly $500 million in capacity on the company’s credit and at-the-market facilities,” wrote Andrew Carter, cannabis analyst at investment bank Stifel Financial Corp in response to a Wednesday afternoon news report that speculated on impending layoffs.

“The rumoured reductions would manifest in roughly C$20 million in annual savings, though this pales in comparison to the C$160 million EBITDA loss we estimate for FY20,” he wrote.

“Unfortunately, 10 per cent in layoffs is not nearly enough expense cutting for Aurora to turn the corner in terms of operating profitability. It would be like putting a band-aid on a major artery wound when a tourniquet would be required to stem the bleeding,” said cannabis analyst Chris Damas, author of The BCMI Report.

Bullboard Posts